IP Library Granted Patent US 9,040,510
Granted Patent B2
US 9,040,510 · App. 12/410,513 · Granted May 26, 2015

Interaction control of cationic biocides using labile anionic polyelectrolytes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,040,510
App. No.
12/410,513
Granted
May 26, 2015
Kind
B2
Abstract

Methods of inhibiting the uptake of cationic biocides into medical devices such as contact lenses and implants are described. Methods of stabilizing emulsions containing cationic biocides are also described. In particular, the present invention provides for the use of polymers acting as labile anionic polyelectrolytes to reversibly bind cationic biocides. The reversible binding can reduce the deleterious effects of cationic biocides while maintaining biocidal activity. Preferred polymers include galactomannan and polyvinyl alcohol.

Claims (16)

1. A method of using a galactomannan to inhibit uptake of a cationic biocide into hydrogel biomaterials, the method comprising adding to a composition containing a cationic biocide and a borate a galactomannan in an amount to form a concentration between 0.025 to 0.074% w/v, wherein the composition is adapted for use with hydrogel biomaterials.

2. A method according to claim 1 , wherein the pH of the composition is greater than 7.

3. A method according to claim 1 , wherein the galactomannan is hydroxypropyl guar.

4. A method according to claim 3 , wherein the concentration of hydroxypropyl guar is 0.05%.

5. A method according to claim 1 , wherein the cationic biocide is a polymeric quaternary ammonium compound.

6. A method according to claim 5 , wherein the polymeric quaternary ammonium compound is polyquaternium-1.

7. A method of reversibly binding cationic biocides in solution to inhibit uptake of the biocide into hydrogel biomaterials, the method comprising adding hydroxypropyl guar in an amount to form a concentration between 0.025 to 0.074% w/v to a composition containing a cationic biocide and a borate.

8. A method according to claim 7 , wherein the pH of the composition is greater than 7.

9. A method according to claim 8 , wherein the pH of the composition is not greater than 8.

10. A method according to claim 7 , wherein the cationic biocide is a polymeric quaternary ammonium compound.

11. A method according to claim 10 , wherein the polymeric quaternary ammonium compound is polyquaternium-1.

12. A method according to claim 8 , wherein the cationic biocide is a polymeric quaternary ammonium compound.

13. A method according to claim 12 , wherein the polymeric quaternary ammonium compound is polyquaternium-1.

14. A method according to claim 13 , wherein the concentration of hydroxypropyl guar is about 0.05 w/v %.

15. A method according to claim 7 , wherein the concentration of hydroxypropyl guar is about 0.05 w/v %.

16. A method according to claim 1 , wherein the hydrogel biomaterial is a soft contact lens.

Assignments (3)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Jul 23, 2020
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 053293/0484 →
MERGER Recorded Jul 21, 2020
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 053273/0022 →
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →